<DOC>
	<DOCNO>NCT00058734</DOCNO>
	<brief_summary>The aim trial find immune response HIV boost individual start medicine soon infect . If immune response boost virus , may allow body control HIV without need medication . This study design test new strategy boost immune response HIV evaluate response allow people control HIV without medicine .</brief_summary>
	<brief_title>Therapeutic Vaccination Followed Treatment Interruption HIV Infected Patients</brief_title>
	<detailed_description>The novel strategy use trial mix peptide vaccine dendritic cell individual . The dendritic cell normal cell blood boost immune response . In HIV uninfected people , dendritic cell find strongly activate type immune response may important control HIV . HIV infect HIV uninfected individual study receive one shot dendritic cell alone follow three monthly shot dendritic cell plus vaccine . We monitor immune response peptide vaccine time period . After complete vaccination , HIV infect patient stop HIV medication immune status ( CD4 count ) viral load monitor closely 12 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Both HIV infect HIV uninfected individual eligible study . CD4 cell count 400 cells/mm3 great study entry If HIV infect , initiate antiHIV medicine within 120 day infection If HIV infect , HIV viral load &lt; 50 copies/ml least 3 month prior study entry Current medication regimen least 3 month prior study entry A particular blood type ( HLAA*0201 ) Acceptable method contraception Received investigational drug vaccine within 30 day prior study entry On immunebased therapy ( e.g. , interleukin2 , alpha interferon , immunoglobulin , thalidomide ) within 30 day prior study entry Megesterol acetate within 30 day prior study entry Immunization within 4 week study entry If hepatitis B virus ( HBV ) uninfected high risk HBV infection , patient eligible complete HBV vaccine series . Unstable severe medical condition , include active opportunistic infection require treatment History Hashimoto 's thyroiditis Cancer require chemotherapy within 6 month prior study entry History radiation therapy axillary lymph node Significant laboratory abnormality study entry Pregnant breastfeed History autoimmune disease ( e.g. , rheumatoid arthritis , systemic lupus erythematosus , autoimmune hepatitis , scleroderma , mixed connective tissue disorder ) Allergy gentamicin , tobramycin , streptomycin , amikacin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Dendritic Cell</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>Acute HIV</keyword>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>AIDS</keyword>
	<keyword>HIV Therapeutic Vaccine</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Interruption</keyword>
</DOC>